Tiroid homeostazisi, insülin direnci ve kan parametrelerinin kilo verme üzerine olan etkileri

Year 2021, Volume: 46 Issue: 2, 548 - 554, 30.06.2021

Mehmet Eryılmaz Duygu İlke Yıldırım

Abstract

Amaç: Birçok çalışma, obezitenin artmış serum tirotropin [TSH] ile ilişkili olduğunu göstermektedir, ancak obezite, serbest tiroid hormonları (serbest triiyodotironin [FT3] ve serbest tiroksin [FT4] dahil) arasındaki ilişki hala net değildir. Bu çalışmada bir obezite merkezinde tiroid homeostazisi, insülin direnci ve kan parametrelerinin kilo verme üzerine olan etkilerinin değerlendirilmesi amaçlanmıştır.
Gereç ve Yöntem: Obezite merkezine 1 Kasım 2018 ile 13 Mart 2020 tarihleri arasında başvuran 3918 hastadan 417'si uygun bulunarak bu obezite önleme programı ve retrospektif, tanımlayıcı, kesitsel çalışmaya kabul edilmiştir.
Bulgular: Çalışmada 383’ü kadın hasta olmak üzere toplam 417 hasta ile görüşüldü. Hastaların ortalama yaşı 48.20 ± 11.03 yıldı. Kilo veren grupta; 6. ayda TSH, FT3, BMI, WC, HC, HbA1c ve HOMA-IR indeks değerleri anlamlı olarak daha düşüktü. Bu sonuçlara göre kilo veren hastaların kan parametreleri, TSH, FT3 ve insülin direnci azalmıştır. Kalça çevresi, BMI, BFP, FT3, HbA1c ve FBG, tek değişkenli analizlerimizde kilo kaybının önemli belirleyicileriydi. FT3 (olasılık oranı [OR]: 1. 854;% 95 CI: [1.223-2.811]; p = 0.004), BMI (OR: 0.948;% 95 CI: [0.914-0.984]; p = 0.005) ve FBG (OR: 0.984;% 95 CI: [0.973-0.996]; p = 0.007) kilo kaybını etkileyen çok değişkenli prediktörler olarak tanımlandı.
Sonuç: Bu çalışma, daha düşük BMI ve FBG seviyelerinin ve daha yüksek fT3 konsantrasyonlarının, obez hastalarda daha iyi bir kilo verme potansiyeli ile ilişkili olduğunu önermektedir.

Keywords

Obezite, insülin direnci, tiroid hormonları, kilo kaybı

Effects of thyroid homeostasis, insulin resistance and some parameters on weight loss

Abstract

Purpose: Many studies show that obesity is associated with increased serum thyrotropin [TSH] but the relationship between obesity, free thyroid hormones (including free triiodothyronine [FT3] and free thyroxin [FT4] is still unclear. The aim of this studywas to evaluate the effects of thyroid homeostasis, insulin resistance and blood parameters on weight loss in an obesity center.
Materials and Methods: Of 3918 patients applied to an obesity center between November 1st, 2018 and March 13th, 2020, 417 were found suitable and accepted in this obesity prevention program and retrospective, descriptive, cross-sectional study.
Results: A total of 417 patients were interviewed, 383 were female in this study. The mean age of participants was 48.20±11.03 years. In the group who lost weight; TSH, FT3, BMI, WC, HC, HbA1c and HOMA-IR index values were significantly lower in the sixth month. According to these results, the blood parameters, TSH, FT3 and insülin resistance of the patients are decreased who lose weight. Hip circumference, BMI, BFP, FT3, HbA1c and FBG were important determinants of weight loss in our univariate analyses. FT3 (odds ratio [OR]: 1.854; 95% CI: [1.223-2.811]; p=0.004), BMI (OR: 0.948; 95% CI: [0.914-0.984]; p=0.005) and FBG (OR: 0.984; 95% CI: [0.973-0.996]; p=0.007) were defined as multivariate predictors affecting weight loss.
Conclusion: This study advises that lower BMI and FBG levels, and higher fT3 concentrations are related with a better potential to lose weight in obese patients.

Keywords

Obesity, insulin resistance, thyroid hormones, weight loss

References

• 1. Franco M, Bilal U, Orduñez P, Benet M, Morejón A, Caballero B, et al. Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends. Bmj. 2013;346:f1515.
• 2. Sichieri R, Nascimento Sd, Coutinho W. The burden of hospitalization due to overweight and obesity in Brazil. Cadernos de Saúde Pública. 2007;23:1721-7.
• 3. Molosankwe I, Patel A, Gagliardino JJ, Knapp M, McDaid D. Economic aspects of the association between diabetes and depression: a systematic review. Journal of affective disorders. 2012;142:S42-S55.
• 4. Ghoorah K, Campbell P, Kent A, Maznyczka A, Kunadian V. Obesity and cardiovascular outcomes: a review. European Heart Journal: Acute Cardiovascular Care. 2016;5(1):77-85.
• 5. Kabadi SM, Lee BK, Liu L. Joint effects of obesity and vitamin D insufficiency on insulin resistance and type 2 diabetes: results from the NHANES 2001–2006. Diabetes care. 2012;35(10):2048-54.
• 6. WHO/2020 [Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
• 7. Lundbäck V, Ekbom K, Hagman E, Dahlman I, Marcus C. Thyroid-stimulating hormone, degree of obesity, and metabolic risk markers in a cohort of Swedish children with obesity. Hormone research in paediatrics. 2017;88(2):140-6.
• 8. Collares FM, Korevaar TI, Hofman A, Steegers EA, Peeters RP, Jaddoe VW, et al. Maternal thyroid function, prepregnancy obesity and gestational weight gain—The Generation R Study: A prospective cohort study. Clinical endocrinology. 2017;87(6):799-806.
• 9. Al-Musa HM. Impact of obesity on serum levels of thyroid hormones among euthyroid Saudi adults. Journal of thyroid research. 2017;2017.
• 10. Cho WK, Nam H-K, Kim JH, Rhie Y-J, Chung S, Lee K-H, et al. Thyroid Function in Korean Adolescents with Obesity: Results from the Korea National Health and Nutrition Examination Survey VI (2013–2015). International journal of endocrinology. 2018;2018.
• 11. Sami A, Iftekhar MF, Rauf MA, Sher A. Subclinical Hypothyroidism among local adult obese population. Pakistan journal of medical sciences. 2018;34(4):980.
• 12. Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: An intriguing link. Indian journal of endocrinology and metabolism. 2016;20(4):554.
• 13. Bensenor IM, Goulart AC, Molina MdCB, Peixoto de Miranda EJ, Santos IS, Lotufo PA. Thyrotropin levels, insulin resistance, and metabolic syndrome: a cross-sectional analysis in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Metabolic syndrome and related disorders. 2015;13(8):362-9.
• 14. 2020 [Available from: https://www.obezit.org/.
• 15. 2020 [Available from: www.sertifika.obezit.org.
• 16. [Available from: http://www.temd.org.tr/admin/uploads/tbl_gruplar/20180525144116-2018-05-25tbl_gruplar144108.pdf.
• 17. Xu R, Huang F, Zhang S, Lv Y, Liu Q. Thyroid function, body mass index, and metabolic risk markers in euthyroid adults: a cohort study. BMC endocrine disorders. 2019;19(1):58.
• 18. Bhowmick SK, Dasari G, Levens KL, Rettig KR. The prevalence of elevated serum thyroid-stimulating hormone in childhood/adolescent obesity and of autoimmune thyroid diseases in a subgroup. Journal of the National Medical Association. 2007;99(7):773.
• 19. Bastemir M, Akin F, Alkis E, Kaptanoglu B. Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss medical weekly. 2007;137(2930).
• 20. Mutlu R, Özsu E, Çizmecioğlu FM, Hatun Ş. Şişman çocuklarda hafif TSH yüksekliği: Nasıl bir sorun? Turkish Pediatrics Archive/Turk Pediatri Arsivi. 2011;46(1).
• 21. Marzullo P, Minocci A, Mele C, Fessehatsion R, Tagliaferri M, Pagano L, et al. The relationship between resting energy expenditure and thyroid hormones in response to short-term weight loss in severe obesity. PloS one. 2018;13(10).
• 22. Neves JS, Souteiro P, Oliveira SC, Pedro J, Magalhães D, Guerreiro V, et al. Preoperative thyroid function and weight loss after bariatric surgery. International Journal of Obesity. 2019;43(2):432-6.
• 23. Kazma E. Üniversite öğrencileri arasinda obezite prevalansi ve oluşum nedenlerinin saptanmasi: istanbul aydin üniversitesi fen bilimleri enstitüsü; 2013.
• 24. De Pergola G, Zupo R, Lampignano L, Bonfiglio C, Giannelli G, Osella A, et al. Higher Body Mass Index, Uric Acid Levels, and Lower Cholesterol Levels are Associated with Greater Weight Loss. Endocrine, metabolic & immune disorders drug targets. 2020.
• 25. Chomard P, Vernhes G, Autissier N, Debry G. Serum concentrations of total and free thyroid hormones in moderately obese women during a six-week slimming cure. European journal of clinical nutrition. 1988;42(4):285-93.
• 26. Wani K, Alfawaz H, Alnaami AM, Sabico S, Khattak MNK, Al-Attas O, et al. Effects of a 12-month intensive lifestyle monitoring program in predominantly overweight/obese Arab adults with prediabetes. Nutrients. 2020;12(2):464.
• 27. Baeza I, Vigo L, de la Serna E, Calvo-Escalona R, Merchán-Naranjo J, Rodríguez-Latorre P, et al. The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study. European child & adolescent psychiatry. 2017;26(1):35-46.
• 28. Wanjia X, Chenggang W, Aihong W, Xiaomei Y, Jiajun Z, Chunxiao Y, et al. A high normal TSH level is associated with an atherogenic lipid profile in euthyroid non-smokers with newly diagnosed asymptomatic coronary heart disease. Lipids in health and disease. 2012;11(1):44.